Milestone Pharmaceuticals Inc. Common Shares (MIST)
PHARMACEUTICAL PREPARATIONS
Milestone Pharmaceuticals Inc. Common Shares (MIST) is listed on Nasdaq, where it has traded since May 9, 2019.
- Listed On
- Nasdaq
- Listed Since
- May 9, 2019
- Employees
- 38
- Market Cap
- $98M
About Milestone Pharmaceuticals Inc. Common Shares
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 77 institutions reported holding MIST, with 49.5 million shares worth $66.4 million in aggregate. The largest reported holder was Pavaki Capital Management, with 9.1 million shares worth $12.2 million. Of the 5 largest holders listed below, 1 opened a new position in MIST and 4 added shares during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Pavaki Capital Management | 9,067,848 | $12M | New position |
| Rtw Investments | 7,833,336 | $10M | Added 23.73% |
| Propel Bio Management | 7,429,590 | $10M | Added 80.4% |
| Point72 Asset Management, | 5,411,138 | $7M | Added 398.41% |
| Simplify Asset Management | 3,349,379 | $4M | Added 122.34% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is MIST?
Milestone Pharmaceuticals Inc. Common Shares (MIST) is listed on Nasdaq, where it has traded since May 9, 2019.
Who are the largest institutional holders of MIST?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of MIST were Pavaki Capital Management, Rtw Investments and Propel Bio Management.
How many institutions own MIST?
77 institutions reported a position in MIST for the quarter ended June 30, 2026, worth $66.4 million in total.
Did institutions buy or sell MIST last quarter?
Of the 5 largest reported holders, 1 opened a new position in MIST and 4 added shares during the quarter. Every reported holder and its change is on the SentiSense ownership page for MIST.
Every reported institutional holder, plus insider and congressional trades in MIST, on SentiSense.